{"id":213,"date":"2018-01-19T09:33:08","date_gmt":"2018-01-19T09:33:08","guid":{"rendered":"http:\/\/www.cscr.in\/symposium\/?page_id=213"},"modified":"2024-07-02T09:02:58","modified_gmt":"2024-07-02T03:32:58","slug":"cgts-2021","status":"publish","type":"page","link":"https:\/\/www.cscr.res.in\/symposium\/index.php\/cgts-2021\/","title":{"rendered":"Scientific Program"},"content":{"rendered":"

\"\" <\/strong><\/h4>\n

PROGRAMME SCHEDULE\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 <\/strong><\/span><\/h4>\n

Time shown in IST (Indian Standard Time)\u00a0 \u00a0 \u00a0<\/strong><\/span><\/em><\/span><\/h4>\n

\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 DAY-1: <\/span><\/b>Thursday<\/b>, 1<\/b>st\u00a0 <\/sup>SEPTEMBER, 2022<\/b><\/span><\/span><\/h2>\n\n\n\n\n\n
1:00 to 1:05 PM<\/td>\nPrayer by Chaplain<\/td>\n<\/tr>\n
\n

1:05 to 1:20 PM<\/p>\n<\/td>\n

Welcome remarks: Dr. J V Peter, Director, CMC \/ Dr. Maneesha Inamdar, Director, inStem \/ Dr. Solomon Satishkumar, Principal, CMC<\/td>\n<\/tr>\n
1:20 to 1:30 PM<\/td>\nClosing remarks: Dr. Alok Srivastava, Head, CSCR<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

Session-1:\u00a0 APPLICATIONS OF iPSC TECHNOLOGY<\/strong><\/span><\/p>\n

Chair- Maneesha S. Inamdar<\/strong><\/p>\n<\/td>\n<\/tr>\n

Indian Time<\/strong><\/td>\nTitle<\/strong><\/td>\nSpeaker Name<\/strong><\/td>\n<\/tr>\n
1.30 to 2:00PM<\/td>\nConsistency and reliability of quality testing for induced Pluripotent Stem Cells<\/td>\n\n

Stephen Sullivan\u00a0 \u00a0<\/strong>\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 Global Alliance for iPSC Therapies, UK<\/p>\n<\/td>\n<\/tr>\n

2:00 to 2:30PM<\/td>\nAssuring reproducibility: Sharing data on hPSC – lines and clinical trials<\/td>\nAndreas Kurtz\u00a0<\/strong> \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 Charit\u00e9-Universit\u00e4ts Medizin Berlin and Fraunhofer Institute for Biomedical Engineering, Sulzbach, Germany<\/td>\n<\/tr>\n
2:30 to 3:00PM<\/td>\nCreation of a Haplobank- Initiative in India<\/td>\nDolly Daniel\u00a0 \u00a0<\/strong>\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 Christian Medical College and Centre for Stem Cell Research, Vellore, India<\/td>\n<\/tr>\n
3:00 to 3:15PM<\/td>\n\u00a0 \u00a0Break<\/strong><\/td>\n<\/tr>\n
3:15 to 3:45PM<\/td>\nPoster presentation<\/strong><\/span><\/td>\n<\/tr>\n
\n

Session-2:\u00a0 IMMUNE CELL THERAPY\u00a0<\/strong><\/span><\/p>\n

Chair- Navin Khattry<\/strong><\/p>\n<\/td>\n<\/tr>\n

Indian Time<\/strong><\/td>\nTitle<\/strong><\/td>\nSpeaker Name<\/strong><\/td>\n<\/tr>\n
3:45 to 4:15 PM<\/td>\nCAR-T cell therapy in relapsed\/ refractory DLBCL<\/td>\nHasmukh Jain\u00a0 \u00a0<\/strong>\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 Advanced Centre for Treatment, Research and Education in Cancer, Mumbai, India<\/td>\n<\/tr>\n
4:15 to 4:45 PM<\/td>\nCAR-T cell therapy for haematological malignancies or solid tumours<\/td>\nAvery D. Posey\u00a0 \u00a0<\/strong>\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 University of Pennsylvania, Philadelphia USA<\/td>\n<\/tr>\n
4:45 to 5:15 PM<\/td>\nDonor derived anti-3rd party CD8 T Cells in haploidentical stem cell transplantation and immune cell therapy<\/td>\nAloukick Kumar Singh\u00a0 \u00a0 \u00a0<\/strong>\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 Centre for Stem Cell Research, Vellore, India<\/td>\n<\/tr>\n
5:15 to 5:30PM<\/td>\n\u00a0 \u00a0Break<\/strong><\/td>\n<\/tr>\n
\n

Session-3: GENE THERAPY<\/strong><\/span><\/p>\n

Chair- Soniya Nityanand<\/strong><\/p>\n<\/td>\n<\/tr>\n

Indian Time<\/strong><\/td>\nTitle<\/strong><\/td>\nSpeaker Name<\/strong><\/td>\n<\/tr>\n
5:30 to 6:00PM<\/td>\nNongenotoxic conditioning for transplant of genetically engineered HSCs: Is this the future for HSC-based gene therapy<\/td>\nH. Trent Spencer\u00a0<\/strong>\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 Emory University School of Medicine, Atlanta, USA<\/td>\n<\/tr>\n
6:00 to 6:30PM<\/td>\nGene Therapy for Hemophilia A – What are the current options?<\/td>\nAlok Srivastava\u00a0 \u00a0 \u00a0<\/strong> \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 Christian Medical College and Centre for Stem Cell Research, Vellore, India<\/td>\n<\/tr>\n
6:30 to 7:00PM<\/td>\nGene Therapy for Platelet Derived Factor VIII Production in Hemophilia A<\/td>\nDavid Wilcox\u00a0 \u00a0 \u00a0 \u00a0<\/strong> \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 Medical College of Wisconsin, WI, US<\/td>\n<\/tr>\n
\n

\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 <\/b>KEYNOTE<\/b> ADDRESS\u00a0<\/b><\/span><\/p>\n

Chair- Alok Srivastava \u00a0 \u00a0<\/span> \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0<\/b><\/p>\n<\/td>\n<\/tr>\n

Indian Time<\/strong><\/td>\nTitle<\/strong><\/td>\nSpeaker Name<\/strong><\/td>\n<\/tr>\n
7:00 to 8:00 PM<\/td>\nDeveloping New Transformative Approaches to Genetic Engineering of Hematopoiesis<\/td>\nLuigi Naldini\u00a0<\/strong>\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 San Raffaele Telethon Institute for Gene Therapy and San Raffaele University, Milano, Italy<\/td>\n<\/tr>\n
End of Day-<\/strong>1<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

DAY-2: Fri<\/span><\/b>day<\/b>, 2<\/b>nd\u00a0 <\/sup>SEPTEMBER, 2022<\/b><\/span><\/span><\/h2>\n<\/td>\n<\/tr>\n

\n

\u00a0 Session-4: TECHNOLOGY ADVANCES<\/span><\/strong>
<\/strong><\/p>\n

Chair- Udaykumar Ranga<\/strong><\/p>\n<\/td>\n<\/tr>\n

Indian Time<\/strong><\/td>\nTitle<\/strong><\/td>\nSpeaker Name<\/strong><\/td>\n<\/tr>\n
2:00 to 2:30 PM<\/td>\nAssessing and mitigating off-target effects in therapeutic genome editing<\/td>\nToni Cathomen\u00a0<\/strong> \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 Institute for Transfusion Medicine and Gene Therapy, Germany<\/td>\n<\/tr>\n
2:30 to 3:00 PM<\/td>\nPrecise modelling and correction of a spectrum of \u03b2-thalassaemia mutations in human erythroid cells by base editors<\/td>\nMohankumar Murugesan<\/strong>\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 Centre for Stem Cell Research, Vellore, India<\/td>\n<\/tr>\n
3:00 to 3:30 PM<\/td>\nIgG-cleaving endopeptidase enables in vivo gene therapy in the presence of anti-AAV neutralizing antibodies<\/td>\nSebastien Lacroix-Desmazes<\/strong> Centre de Recherche des Cordeliers, France<\/td>\n<\/tr>\n
3:30 to 4:00 PM<\/td>\nDevelopment of optimized (\u201cOpt\u201d) and generation Y (\u201cGenY\u201d) AAVrh74 vectors for gene therapy of muscular dystrophies<\/td>\nArun Srivastava\u00a0<\/strong> \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 University of Florida, Florida , USA<\/td>\n<\/tr>\n
4:00 to 4:15 PM<\/td>\n \u00a0 \u00a0 \u00a0Break<\/strong><\/td>\n<\/tr>\n
\n

Session-5: Industry Symposium<\/span><\/strong><\/p>\n

Chair- Cartikeya Reddy<\/strong><\/p>\n<\/td>\n<\/tr>\n

Indian Time<\/strong><\/td>\nTitle<\/strong><\/td>\nSpeaker Name<\/strong><\/td>\n<\/tr>\n
4:15 to 4:45 PM<\/td>\nCell therapy solutions for every step \u2013 from discovery to cure<\/td>\nPrathap Naidu\u00a0<\/strong> \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 Thermo Fisher Scientific, Hyderabad, India<\/td>\n<\/tr>\n
4:45 to 5:15PM<\/td>\nDroplet Digital PCR for Cell and Gene Therapy \u2014 ddPCR resolves problems with qPCR<\/td>\nAjay Deepak Baskaran\u00a0 \u00a0<\/strong> \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 Bio-Rad Laboratories (India) Pvt Ltd., Haryana, India<\/td>\n<\/tr>\n
5:15 to 6:00 PM<\/td>\n\u00a0 \u00a0 Poster presentation<\/span><\/span><\/strong><\/td>\n<\/tr>\n
\n

Session-6: MANUFACTURING AND REGULATORY ASPECTS IN CELL AND GENE THERAPY<\/strong><\/span><\/p>\n

Chair- Cartikeya Reddy<\/strong><\/p>\n<\/td>\n<\/tr>\n

Indian Time<\/strong><\/td>\nTitle<\/strong><\/td>\nSpeaker Name<\/strong><\/td>\n<\/tr>\n
6:00 to 6:30 PM<\/td>\n\n

Manufacturing of Lentiviral Vector (LV) for Haemophilia A<\/p>\n

Lentiviral mediated genetic modification of HSC from Haemophilia A patients<\/p>\n<\/td>\n

\n

William Swaney\u00a0 \u00a0 \u00a0<\/strong>\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 Expression Manufacturing LLC, Georgia, USA<\/p>\n

Gurbind Singh\u00a0 \u00a0<\/strong>\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 Centre for Stem Cell Research, Vellore, India<\/p>\n<\/td>\n<\/tr>\n

6:30 to 7:00 PM<\/td>\nAdvanced HSC clinical trials in the Necker hospital GMP facility<\/td>\nElisa Magrin & Jihene Benlagha<\/strong> Necker-Enfants Malades Hospital, Paris, France<\/td>\n<\/tr>\n
7:00 to 7:30 PM<\/td>\nVirus-specific T Cell Engineering for Clinical Applications<\/td>\nAdrian Gee\u00a0 \u00a0 \u00a0<\/strong>\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 Center for Cell & Gene Therapy, Baylor College of Medicine Houston, TX, US<\/td>\n<\/tr>\n
\n

KEYNOTE ADDRESS<\/span><\/strong><\/p>\n

Chair-RV Shaji<\/strong><\/p>\n<\/td>\n<\/tr>\n

Indian Time<\/strong><\/td>\nTitle<\/strong><\/td>\nSpeaker Name<\/strong><\/td>\n<\/tr>\n
7:30 to 8:30 PM<\/td>\nEvolution of lentiviral vector mediated gene modified autologous HSCs for the treatment of hemoglobin disorders<\/td>\nMark C. Walters\u00a0 \u00a0<\/strong> \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 UCSF Benioff Children’s Hospitals, California, USA<\/td>\n<\/tr>\n
End of Day-2<\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n

DAY-3: Satur<\/span><\/b>day<\/b>, 3<\/b>rd\u00a0 <\/sup>SEPTEMBER, 2022<\/b><\/span><\/span><\/h2>\n<\/td>\n<\/tr>\n

\n

Session-7: CELL AND GENE THERAPY- INDUSTRY UPDATES<\/span><\/strong>
<\/strong><\/p>\n

Chair- Vijay Chandru<\/strong><\/p>\n<\/td>\n<\/tr>\n

Indian Time<\/strong><\/td>\nTitle<\/strong><\/td>\nSpeaker Name<\/strong><\/td>\n<\/tr>\n
2:00 to 2:30 PM<\/td>\nFuture of Vaccinology-mRNA<\/td>\nAjay Singh\u00a0 \u00a0 \u00a0<\/strong> \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 Gennova Biopharma Ltd., Pune, India<\/td>\n<\/tr>\n
2:30 to 3:00 PM<\/td>\nCAR-T cell Therapy-Bench to Bedside-the Immuneel approach<\/td>\nAnil Kamat\u00a0<\/strong> \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 Immuneel Therapeutics Private Limited, Bangalore, India<\/td>\n<\/tr>\n
3:00 to 3:30 PM<\/td>\nAllogeneic, Off the Shelf, Pooled, Bone marrow derived Mesenchymal Stromal Cells (Stempeucel\u00ae) \u2013 a Potential break through therapy for Grade II & III Osteoarthritis knee<\/td>\nPawan Kumar Gupta<\/strong> Stempeutics Research Pvt. Ltd., Bangalore, India<\/td>\n<\/tr>\n
3:30 to 3:45 PM<\/td>\n\u00a0 \u00a0 \u00a0Break<\/strong><\/td>\n<\/tr>\n
\n

Session-8: GENE EDITING<\/strong><\/span><\/p>\n

Chair- Souvik Maiti<\/strong><\/p>\n<\/td>\n<\/tr>\n

Indian Time<\/strong><\/td>\nTitle<\/strong><\/td>\nSpeaker Name<\/strong><\/td>\n<\/tr>\n
3:45 to 4:15 PM<\/td>\nA Mutation-Agnostic Hematopoietic Stem Cell Gene editing approach<\/td>\nJustin S Antony\u00a0<\/strong>\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 University of T\u00fcbingen, Germany<\/td>\n<\/tr>\n
4:15 to 4:45 PM<\/td>\nGenome editing approaches for beta-hemoglobinopathies<\/td>\nAnnarita Miccio\u00a0<\/strong> \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 Institute of genetic diseases Imagine, INSERM UMR1163, Universite\u2019 Paris Cite\u2019 Paris, France<\/td>\n<\/tr>\n
4:45 to 5:15 PM<\/td>\nThe CD34+CD90+HSCs as a target cell for CCR5 gene editing<\/td>\nSaravanabhavan Thangavel<\/strong>
Centre for Stem Cell Research, Vellore, India<\/td>\n<\/tr>\n
5:15 to 6:00 PM<\/td>\n\u00a0 \u00a0 Poster presentation<\/span><\/span><\/strong><\/td>\n<\/tr>\n
\n

Session-9: NON-VIRAL NUCLEIC ACID TRANSFER<\/strong><\/span><\/p>\n

Chair- Arabinda Chaudhuri<\/strong><\/p>\n<\/td>\n<\/tr>\n

Indian Time<\/strong><\/td>\nTitle<\/strong><\/td>\nSpeaker Name<\/strong><\/td>\n<\/tr>\n
6:00 to 6:30 PM<\/td>\nSmart lipid nanoparticle enabled mRNA vaccine for SARS-CoV2<\/td>\nSrujan Marepally<\/strong>
Centre for Stem Cell Research, Vellore, India<\/td>\n<\/tr>\n
6:30 to 7:00 PM<\/td>\nEngineering mesenchymal stem cells by modulating tissue factor gene expression using short interfering RNA<\/td>\nOommen P. Oommen<\/strong>
Faculty of Medicine and Health Technology, Tampere University, Finland,<\/td>\n<\/tr>\n
7:00 to 7:30 PM<\/td>\nBoosting intracellular delivery of mRNA therapeutics and its applications<\/td>\nGaurav Sahay<\/strong>
Oregon State University, Oregon, US<\/td>\n<\/tr>\n
End of Day-3<\/strong><\/td>\n<\/tr>\n
\u00a0<\/td>\n\u00a0<\/td>\n\u00a0<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

\"\"<\/h3>\n

CGTS 2022 SCIENTIFIC PROGRAM \u2013 Click to view \/ Download<\/strong><\/span><\/a><\/h3>\n

Time shown in IST (Indian Standard Time)<\/em><\/p>\n

CGTS 2022 ABSTRACT BOOK \u2013 Click to view \/ download<\/a><\/p>\n

CGTS 2022 E-POSTER \u2013 Click to view \/ download<\/a>\u00a0 \u00a0<\/p>\n

\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0\u00a0<\/b><\/span><\/h2>\n

\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0<\/span><\/strong><\/p>\n\n\n\n","protected":false},"excerpt":{"rendered":"

PROGRAMME SCHEDULE\u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 \u00a0 […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"template\/fullwidth.php","meta":[],"_links":{"self":[{"href":"https:\/\/www.cscr.res.in\/symposium\/index.php\/wp-json\/wp\/v2\/pages\/213"}],"collection":[{"href":"https:\/\/www.cscr.res.in\/symposium\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.cscr.res.in\/symposium\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.cscr.res.in\/symposium\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.cscr.res.in\/symposium\/index.php\/wp-json\/wp\/v2\/comments?post=213"}],"version-history":[{"count":353,"href":"https:\/\/www.cscr.res.in\/symposium\/index.php\/wp-json\/wp\/v2\/pages\/213\/revisions"}],"predecessor-version":[{"id":2676,"href":"https:\/\/www.cscr.res.in\/symposium\/index.php\/wp-json\/wp\/v2\/pages\/213\/revisions\/2676"}],"wp:attachment":[{"href":"https:\/\/www.cscr.res.in\/symposium\/index.php\/wp-json\/wp\/v2\/media?parent=213"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}